Skulle Implants was established in 2011 to commercialize innovations and research findings concerning bioactive glasses and the successful use of fiber-reinforced composites in dentistry. Fundamental research of bioactive glasses was carried out at the University of Turku and Åbo Akademi University in Finland already in the 1980s. Following the intensive composite material research at the Institute of Dentistry, University of Turku in the late 1990s, the introduction of dental fiber-reinforced composites for clinical and commercial use created a solid foundation for a completely new type of bone surgery implants based on the GLACE™ technology. The technology and unique production of implants combine the benefits of durable and imaging-compatible fiber-reinforced composites and the bone forming capability of bioactive glasses. As a result, medical implantology has shifted from metal-containing implants to novel high-tech composite implants of individual anatomic design and contour. GLACE™ – Good to the bone The active innovation and patenting policy resulted in the establishment of Skulle Implants. Globally, it is the only Class III (European Medical Device Regulation) medical device producing company that focuses on the production of unique custom-made bioactive glass fiber composite implants for bone repair and replacement. In 2014, the company launched its new production facilities in Turku and received accreditation for starting the production of custom-made implants. Skulle Implants aims to expand the clinical indications of GLACE™ platform technology in close collaboration with clinical experts and material scientists.
View Top Employees from Skulle Implants OyWebsite | http://www.skulleimplants.com |
Revenue | $4 million |
Employees | 10 (4 on RocketReach) |
Founded | 2011 |
Address | 60 Lemminkäisenkatu, Turku, Southwest Finland 20520, FI |
Phone | +358 10 5262337 |
Fax | +358 10 5262349 |
Technologies |
JavaScript,
HTML,
Twitter
+13 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Manufacturing General, Manufacturing |
SIC | SIC Code 80 Companies, SIC Code 807 Companies |
NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Skulle Implants Oy employee's phone or email?
The Skulle Implants Oy annual revenue was $4 million in 2024.
Jan Prokofjeff is the Chief Commercial Officer of Skulle Implants Oy.
4 people are employed at Skulle Implants Oy.
Skulle Implants Oy is based in Turku, Southwest Finland.
The NAICS codes for Skulle Implants Oy are [339, 33].
The SIC codes for Skulle Implants Oy are [80, 807].